Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controls.
作者信息
Mavrogeni Sophie
出版信息
Blood Transfus. 2011 Jul;9(3):343-5. doi: 10.2450/2011.0099-10. Epub 2011 Apr 7.
Abstract
摘要
相似文献
1
Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controls.与重型地中海贫血患者及对照组相比，通过MRI T2*评估多次输血且反复失血患者的心肌和肝脏铁负荷。
Blood Transfus. 2011 Jul;9(3):343-5. doi: 10.2450/2011.0099-10. Epub 2011 Apr 7.
2
comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.采用T2*磁共振成像评估不同长期铁螯合方案对重型β地中海贫血患者心肌和肝脏铁浓度的影响比较
Int J Hematol. 2007 Dec;86(5):385-9. doi: 10.1007/BF02983992.
3
Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine.尽管肝脏铁水平较低且严格遵守去铁胺治疗方案，但仍发生了地中海贫血铁过载性心肌病。
Acta Haematol. 2006;115(1-2):106-8. doi: 10.1159/000089475.
4
MRI for Iron Overload in Thalassemia.地中海贫血中铁过载的磁共振成像
Hematol Oncol Clin North Am. 2018 Apr;32(2):277-295. doi: 10.1016/j.hoc.2017.11.012.
5
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.血清铁蛋白、磁共振成像T2及T2*在使用国际螯合委员会去铁酮/去铁胺联合方案诊断地中海贫血中铁过载及铁储存正常化的铁动力学方面的用途及局限性
Hemoglobin. 2009;33(5):312-22. doi: 10.3109/03630260903213231.
6
Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.采用T2*磁共振成像及Excel电子表格对突尼斯重型地中海贫血患者进行后处理，评估心肌和肝脏铁过载情况。
Ann Hematol. 2017 Jan;96(1):133-139. doi: 10.1007/s00277-016-2841-5. Epub 2016 Oct 12.
7
Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy.通过使用地拉罗司/去铁胺联合治疗将地中海贫血患者的体内铁储存降低到正常范围水平，并此后通过地拉罗司单药治疗维持这一水平。
Eur J Haematol. 2010 Nov;85(5):430-8. doi: 10.1111/j.1600-0609.2010.01499.x.
8
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.静脉注射去铁胺逆转铁过载性心肌病过程中心肌铁清除情况：一项使用T2*心血管磁共振的前瞻性研究
Br J Haematol. 2004 Nov;127(3):348-55. doi: 10.1111/j.1365-2141.2004.05202.x.
9
A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.一种基于血清铁蛋白和心脏磁共振成像T2*对地中海贫血患者进行分层的实用螯合方案。
Hemoglobin. 2009;33(5):323-31. doi: 10.3109/03630260903211979.
10
MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.用于定量评估重型地中海贫血患者肝脏和心脏铁含量的MRI：印度人群的初步研究
Indian J Pediatr. 2017 Apr;84(4):276-282. doi: 10.1007/s12098-017-2310-8. Epub 2017 Feb 24.
本文引用的文献
1
Liver iron content determination by magnetic resonance imaging.磁共振成像测定肝脏铁含量。
World J Gastroenterol. 2010 Apr 7;16(13):1587-97. doi: 10.3748/wjg.v16.i13.1587.
2
Evaluation of myocardial iron overload using magnetic resonance imaging.使用磁共振成像评估心肌铁过载。
Blood Transfus. 2009 Jul;7(3):183-7. doi: 10.2450/2008.0063-08.
3
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.骨髓增生异常综合征中贫血及输血性铁过载的临床相关性
Hematology Am Soc Hematol Educ Program. 2008:166-75. doi: 10.1182/asheducation-2008.1.166.
4
Cardiac iron across different transfusion-dependent diseases.不同输血依赖疾病中的心脏铁沉积
Blood Rev. 2008 Dec;22 Suppl 2(Suppl 2):S14-21. doi: 10.1016/S0268-960X(08)70004-3.
5
T2* magnetic resonance and myocardial iron in thalassemia.地中海贫血中的T2*磁共振成像与心肌铁含量
Ann N Y Acad Sci. 2005;1054:373-8. doi: 10.1196/annals.1345.045.
Zotero 插件